Total Payments
$2,711
2023 Payments
$640.87
Companies
31
Transactions
148
Medicare Patients
1,216
Medicare Billing
$138,104
Payment Breakdown by Category
Food & Beverage$2,711 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,711 | 148 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $794.53 | 47 | $0 (2023) |
| Novo Nordisk Inc | $299.39 | 17 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $289.33 | 13 | $0 (2023) |
| Mylan Specialty L.P. | $211.42 | 8 | $0 (2023) |
| Amgen Inc. | $118.31 | 7 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $110.60 | 6 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $106.44 | 6 | $0 (2023) |
| GlaxoSmithKline, LLC. | $83.43 | 4 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $82.77 | 4 | $0 (2023) |
| Lilly USA, LLC | $69.19 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $640.87 | 30 | AstraZeneca Pharmaceuticals LP ($151.01) |
| 2022 | $964.89 | 56 | ABBVIE INC. ($253.67) |
| 2021 | $1,105 | 62 | AbbVie Inc. ($492.78) |
All Payment Transactions
148 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/08/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Oncology | ||||||
| 08/03/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Inflammation | ||||||
| 08/01/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/19/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: PSYCHIATRY | ||||||
| 07/04/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Diabetes Care | ||||||
| 06/22/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/20/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Inflammation | ||||||
| 06/14/2023 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardiovascular | ||||||
| 06/07/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.07 | General |
| 05/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Cardio-renal | ||||||
| 05/09/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Inflammation | ||||||
| 05/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: DIABETES | ||||||
| 04/25/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Diabetes | ||||||
| 04/21/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $31.16 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/13/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Inflammation | ||||||
| 04/06/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Respiratory | ||||||
| 03/28/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Neuroscience | ||||||
| 03/21/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/09/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/08/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Cardio-renal | ||||||
| 02/23/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Respiratory | ||||||
| 02/15/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 434 | 586 | $92,202 | $36,689 |
| 2022 | 6 | 428 | 609 | $93,221 | $44,452 |
| 2021 | 1 | 145 | 360 | $66,600 | $26,750 |
| 2020 | 4 | 209 | 454 | $85,562 | $30,214 |
Total Patients
1,216
Total Services
2,009
Medicare Billing
$138,104
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 209 | 338 | $67,874 | $25,812 | 38.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 66 | 73 | $7,258 | $4,089 | 56.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 30 | 39 | $6,647 | $3,117 | 46.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 19 | $3,990 | $1,488 | 37.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,102 | $1,070 | 26.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 18 | 18 | $612.00 | $296.28 | 48.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 18 | 18 | $486.00 | $236.16 | 48.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 24 | 26 | $468.00 | $218.40 | 46.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 20 | 21 | $462.00 | $217.35 | 47.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 19 | 19 | $304.00 | $144.59 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 204 | 319 | $55,785 | $23,313 | 41.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 128 | 185 | $18,393 | $12,188 | 66.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 34 | 43 | $7,328 | $3,852 | 52.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $6,239 | $2,993 | 48.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $4,848 | $1,938 | 40.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 18 | 18 | $628.00 | $168.49 | 26.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 145 | 360 | $66,600 | $26,750 | 40.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 161 | 406 | $75,110 | $26,723 | 35.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 23 | 23 | $6,578 | $2,029 | 30.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 13 | 13 | $3,250 | $1,317 | 40.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 12 | 12 | $624.00 | $144.72 | 23.2% |
About Julio Giron, PA-C
Julio Giron, PA-C is a Physician Assistant healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2009. The National Provider Identifier (NPI) number assigned to this provider is 1962646653.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Julio Giron, PA-C has received a total of $2,711 in payments from pharmaceutical and medical device companies, with $640.87 received in 2023. These payments were reported across 148 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,711).
As a Medicare-enrolled provider, Giron has provided services to 1,216 Medicare beneficiaries, totaling 2,009 services with total Medicare billing of $138,104. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Henderson, NV
- Active Since 04/24/2009
- Last Updated 09/05/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1962646653
Products in Payments
- UBRELVY (Drug) $426.34
- VRAYLAR (Drug) $283.55
- FARXIGA (Drug) $185.83
- NURTEC ODT (Drug) $152.85
- YUPELRI (Drug) $136.09
- JARDIANCE (Drug) $106.44
- BREZTRI (Drug) $103.50
- NUCALA (Biological) $83.43
- Kerendia (Drug) $82.77
- Otezla (Drug) $79.34
- Yupelri (Drug) $75.33
- Ozempic (Drug) $59.37
- Saxenda (Drug) $44.33
- CAPLYTA (Drug) $43.45
- EMGALITY (Drug) $43.29
- FREESTYLE LIBRE 2 (Device) $41.75
- RYBELSUS (Drug) $41.26
- NEXLETOL (Drug) $39.37
- Wegovy (Drug) $39.29
- BELSOMRA (Drug) $36.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Henderson
Anna Liang, Physician Assistant, PHYSICIAN ASSISTANT
Physician Assistant — Payments: $9,518
Physician Assistant $9,518
Rachel Tennis, Pa-C, PA-C
Physician Assistant — Payments: $8,011
Physician Assistant $8,011
Stephanie Shibata, Pa-C, PA-C
Physician Assistant — Payments: $7,733
Physician Assistant $7,733
Benjamin Reese, Pa-C, PA-C
Physician Assistant — Payments: $6,807
Physician Assistant $6,807
Andrea Alessi, Pa, PA
Physician Assistant — Payments: $6,647
Physician Assistant $6,647
Laurie Michlin, Apn, APN
Physician Assistant — Payments: $6,402
Physician Assistant $6,402